Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Omega Transaminase Mutant. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110540975B reveals high-efficiency biocatalytic route for sitagliptin precursors, offering superior stereoselectivity and reduced environmental impact for pharma supply chains.